GlaxoSmithKline PLC
16 August 2005
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
Following an administrative error in the calculation of the notional
re-investment of the dividend paid to shareholders on 7 July 2005, which the
Company announced on 11 July 2005, the Administrators of the GlaxoSmithKline
Performance Share Plan notified the Company and the under-mentioned persons on
15 August 2005 of a change to their notional interests in Ordinary Shares at a
price of £13.28 per Ordinary Share and Ordinary Share ADRs at a price of $50.03
per ADR.
The correct increase in the notional interests in Ordinary Shares and Ordinary
Share ADRs is as follows:
Dr J P Garnier 3,126.369 ADRs
Mr J Heslop 117.838 Ordinary Shares
Dr T Yamada 937.911 ADRs
Mr R Bondy 1,193.502 Ordinary Shares
Mr W Calhoun 390.797 ADRs
Mr M Dunoyer 449.501 Ordinary Shares
Mr R Greig 390.797 ADRs
Mr D Phelan 601.826 ADRs
Dr D Pulman 394.878 Ordinary Shares
191.711 ADRs
Mr D Stout 1,156.757 ADRs
Mr C Viehbacher 601.826 ADRs
Mr A Witty 1,051.346 Ordinary Shares
Mrs J Younger 271.25 Ordinary Shares
Mr J Ziegler 601.826 ADRs
The notional dividends accrued will be paid out in proportion to the percentage
of participants' Performance Share Plan holdings that vest following the end of
the relevant three year measurement period.
This notification relates to a transaction notified in accordance with
Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b) and replaces RNS Announcement
7589O released on 11 July 2005.
S M Bicknell
Company Secretary
16 August 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.